NMR Cryoplatform Replacements 75N98026R00121
Summary
AI-generated · Jul 08, 2026Two NMR cryoplatform replacement units are being sought as a brand-name or equal requirement to Bruker Biospin CCU05 (or newer) with cooling performance equal to or better than the current CCU04 end-of-life systems. This is a market survey to assess the availability and technical capability of qualified small businesses to provide these replacements.
Submit a capability statement showing your experience and ability to fulfill the requirement, including descriptive literature, proposed delivery timeline, warranties, and other information demonstrating compliance. Include firm size and business type, and a point of contact with authority to discuss responses. Reference solicitation 75N98026R00121 in your submission; responses that do not provide sufficient information will be considered non-responsive.
The National Institutes of Health (NIH), Office of the Director (OD) is conducting a market survey to determine the availability and technical capability of qualified small businesses, including 8(a) small businesses, small, disadvantaged businesses, woman-owned small businesses, service-disabled veteran-owned small businesses or HUBZone small businesses capable of providing new Brand name or Equal to: Two NMR cryoplatform replacements 1. Quantity two (2) current-generation cryoplatform units equivalent to or newer than Bruker Biospin CCU05 and 2. Equivalent or improved cooling performance relative to the current end-of-life Bruker Biospin CCU04 systems. Interested firms with the capability of providing all the required items shall submit a capability statement to assist the Government in determining in accordance with the Federal Acquisition Regulation 19.104-1. The intended procurement will be classified under North American Industrial Classification (NAICS) code 334516 with a size standard of 1000e. All respondents are required to identify their firm s size and type of business. Interested firms responding to this market survey must provide (a) capability statement demonstrating their experience, skills and capability to fulfill the Government s requirements in this notice. The capability statement shall be in sufficient enough details so that the Government can determine the experience and capability of your firm to provide the items and services in this posting/notice. Offers must also be accompanied by descriptive literature, delivery timeframe, warranties and other information that demonstrates that the offer meets all the foregoing requirements. Capability statements must include the name and telephone number, and email address of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to the market survey that do not provide sufficient information for evaluation will be considered non-responsive. A copy of the capability statement must be received via email to robinsti@mail.nih.gov Attn: Tina Robinson prior to 4:30 pm eastern standard time on July 16, 2026. Capability statement must reference solicitation# 75N98026R00121. Submission by email must also reference solicitation # 75N98026R00121 on the subject line of the email. Any questions must be sent via email to robinsti@mail.nih.gov and must include solicitation# 75N98026R00121 on the subject line of email. Capability statements, etc will not be returned to firm/sender. This synopsis is for information and planning purposes and is not to be construed as a commitment by the Government, nor will the Government pay for information solicited.
From Sources Sought posted on Jul 07, 2026Notice history
1Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA